[go: up one dir, main page]

PE20091524A1 - Derivados de 2-aminopirimidina - Google Patents

Derivados de 2-aminopirimidina

Info

Publication number
PE20091524A1
PE20091524A1 PE2008002136A PE2008002136A PE20091524A1 PE 20091524 A1 PE20091524 A1 PE 20091524A1 PE 2008002136 A PE2008002136 A PE 2008002136A PE 2008002136 A PE2008002136 A PE 2008002136A PE 20091524 A1 PE20091524 A1 PE 20091524A1
Authority
PE
Peru
Prior art keywords
alkyl
pyrimidin
methylamine
amine
atoms
Prior art date
Application number
PE2008002136A
Other languages
English (en)
Inventor
Gonzalez Elena Carceller
Bernado Marina Virgili
Via Josep Marti
Fuentes Eva Maria Medina
Original Assignee
Palau Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Palau Pharma Sa filed Critical Palau Pharma Sa
Publication of PE20091524A1 publication Critical patent/PE20091524A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

REFERIDA A COMPUESTOS DERIVADOS DE 2-AMINO-PIRIMIDINA DE FORMULA (I), DONDE R1 ES (i) O (ii); R2 Y R3 FORMAN JUNTO AL ATOMO DE N AL QUE ESTAN UNIDOS, UN HETEROCICLICO SATURADO QUE PUEDE SER MONOCICLICO DE 4 A 7 ATOMOS, UN BICICLICO CON PUENTE DE 7 A 8 ATOMOS, UN BICICLICO FUSIONADO DE 8 A 12 ATOMOS, ENTRE OTROS; R4 Y R5 SON CADA UNO H, ALQUILO(C1-C4), ARILO, ENTRE OTROS; R6 ES ALQUILO(C1-C8), CICLOALQUILO(C3-C8)ALQUILO(C0-C6), Ar1-ALQUILO(C0-C4), ENTRE OTROS; Ar1 ES FENILO OPCIONALMENTE SUSTITUIDO POR HALO, CN, ALQUILO(C1-C4), ENTRE OTROS; R7 ES ANILLO HETEROCICLICO SATURADO MONOCILICO DE 4 A 7 ATOMOS QUE CONTIENE SOLO UN HETEROATOMO DE O, OPCIONALMENTE SUSTITUIDO POR HALO O ALQUILO(C1-C4); n ES 1, 2 O 3; p ES 0, 1 O 2. SON COMPUESTOS PREFERIDOS: 4-CICLOHEXILOXIMETIL-6-(3-(METILAMINO)AZETIDIN-1-IL)PIRIMIDIN-2-AMINA, 4-CICLOHEXILOXIMETIL-6-((3R)-3-(METILAMINO)PIRROLIDIN-1-IL)PIRIMIDIN-2-AMINA, 4-(CICLOPROPILMETOXIMETIL)-6-(3-(METILAMINO)AZETIDIN-1-IL)PIRIMIDIN-2-AMINA, ENTRE OTROS. SE REFIERE TAMBIEN A SU PROCEDIMIENTO DE PREPARACION Y A COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN. DICHOS COMPUESTOS SON ANTAGONISTAS DEL RECEPTOR H4 SIENDO UTILES PARA EL TRATAMIENTO DEL DOLOR, ENFERMEDADES ALERGICAS, ENFERMEDADES INMUNOLOGICAS, ENTRE OTROS
PE2008002136A 2007-12-19 2008-12-18 Derivados de 2-aminopirimidina PE20091524A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07382003 2007-12-19
US3423908P 2008-03-06 2008-03-06

Publications (1)

Publication Number Publication Date
PE20091524A1 true PE20091524A1 (es) 2009-09-25

Family

ID=39247222

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008002136A PE20091524A1 (es) 2007-12-19 2008-12-18 Derivados de 2-aminopirimidina

Country Status (4)

Country Link
AR (1) AR069813A1 (es)
PE (1) PE20091524A1 (es)
TW (1) TW200940529A (es)
WO (1) WO2009077608A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008000467A1 (es) 2007-02-14 2008-08-22 Janssen Pharmaceutica Nv Compuestos derivados de 2-aminopirimidina, moduladores del receptor histamina h4; su procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno inflamatorio seleccionado de alegia, asma
EP2188274A4 (en) 2007-08-03 2011-05-25 Boehringer Ingelheim Int VIRAL POLYMERASE HEMMER
NZ585370A (en) 2007-12-19 2012-09-28 Boehringer Ingelheim Int Viral polymerase inhibitors
EP2201982A1 (en) 2008-12-24 2010-06-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Histamine H4 receptor antagonists for the treatment of vestibular disorders
SI2493895T1 (sl) 2009-10-29 2017-10-30 Vectura Limited Derivati heteroarila, ki vsebujejo N, kot inhibitorji JAK3 kinaze
CA2783209C (en) * 2009-12-22 2017-03-14 Msd Oss B.V. Amino-heteroaryl derivatives as hcn blockers
EP2516420B8 (en) 2009-12-23 2018-10-17 Medicis Pharmaceutical Corporation Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists
SI2858647T1 (sl) 2012-06-08 2018-11-30 Sensorion Inhibitorji receptorja H4 za zdravljenje tinitusa
CN103922928A (zh) * 2013-10-31 2014-07-16 北京利和知信科技有限公司 适用于制备烯烃聚合催化剂的环取代醚酸酯化合物
GB201817047D0 (en) 2018-10-19 2018-12-05 Heptares Therapeutics Ltd H4 antagonist compounds
GB202005858D0 (en) * 2020-04-22 2020-06-03 Heptares Therapeutics Ltd H4 Antagonist compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1505064A1 (en) * 2003-08-05 2005-02-09 Bayer HealthCare AG 2-Aminopyrimidine derivatives
WO2005054239A1 (en) * 2003-12-05 2005-06-16 Bayer Healthcare Ag 2-aminopyrimidine derivatives
KR20080043840A (ko) * 2005-09-13 2008-05-19 팔라우 파르마 에스에이 히스타민 h4 수용체 활성의 조정자로서 2-아미노피리미딘유도체
NL2000323C2 (nl) * 2005-12-20 2007-11-20 Pfizer Ltd Pyrimidine-derivaten.
EP2066645A2 (en) * 2006-09-12 2009-06-10 UCB Pharma S.A. 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions

Also Published As

Publication number Publication date
WO2009077608A1 (en) 2009-06-25
TW200940529A (en) 2009-10-01
AR069813A1 (es) 2010-02-17

Similar Documents

Publication Publication Date Title
PE20091524A1 (es) Derivados de 2-aminopirimidina
PE20110397A1 (es) Compuestos que modulan selectivamente el receptor cb2
PE20091035A1 (es) Derivados de 2-aminopirimidina
PE20080409A1 (es) Compuestos que modulan en el receptor cb2
PE20120031A1 (es) Compuestos aril metil benzoquinazolinona como moduladores alostericos positivos del receptor m1
EA200970326A1 (ru) Алкильные производные в качестве метаботропных рецепторов глутамата
AR072952A1 (es) Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso
PE20070848A1 (es) Derivados de pirimidina como ligandos del receptor de histamina h4
PE20190446A1 (es) Moduladores alostericos positivos del receptor muscarinico de acetilcolina m4
PE20081845A1 (es) Nuevos derivados de aminopirimidina como inhibidores de plk1
PE20130774A1 (es) Compuestos heterociclicos activadores de ampk y metodos para emplearlos
AR054024A1 (es) Derivados de piridina -3- carboxamida como agonistas inversos de cb1
PE20151601A1 (es) Compuestos novedosos de pirimidina y piridina y su uso
CO6190626A2 (es) Compuestos y composiciones como inhibidores de proteasa activadora de canal
PE20090215A1 (es) Compuestos derivados de imidazopiridazinas como inhibidores de cinasa
PE20090241A1 (es) Derivados de quinolina-carboxamida en calidad de antagonistas de p2y12
NO20050418L (no) Kondenserte pyridiner og pyrimidiner med TIE2(TEK) aktivitet
AR068509A1 (es) Antagosnistas del receptor de bradiquinina b1
PE20240930A1 (es) Analogos de benzoazepina como agentes inhibidores de la tirosina cinasa de bruton
AR049696A1 (es) Derivados de indol
PE20090622A1 (es) Nuevos derivados de bencimidazol sustituido
PE20081665A1 (es) Antagonistas del receptor de dopamina 2 de rapida disociacion
PE20090592A1 (es) Nuevos derivados de piperazina-amida
AR069814A1 (es) Derivados de 4 amino-pirimidina, proceso de preparacion y composiciones farmaceuticas que los contienen
AR065587A1 (es) Aminoamidas como antagonistas de orexina

Legal Events

Date Code Title Description
FD Application declared void or lapsed